Yan Zheng

5.8k total citations · 3 hit papers
48 papers, 3.0k citations indexed

About

Yan Zheng is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yan Zheng has authored 48 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Immunology. Recurrent topics in Yan Zheng's work include Cancer, Hypoxia, and Metabolism (9 papers), Bone and Dental Protein Studies (7 papers) and Extracellular vesicles in disease (5 papers). Yan Zheng is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Bone and Dental Protein Studies (7 papers) and Extracellular vesicles in disease (5 papers). Yan Zheng collaborates with scholars based in China, United States and Germany. Yan Zheng's co-authors include Qiongzhu Dong, Lun–Xiu Qin, Hu‐Liang Jia, Beiyuan Hu, Yan Fu, Tiantian Zou, Xiaotian Shen, Haoting Sun, Ying Zhu and Xiaomei Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Hepatology.

In The Last Decade

Yan Zheng

44 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and characterization of exosomes for cancer research

2020 376 citations Le Zhu, Haoting Sun et al. Journal of Hematology & Oncology profile →
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade

2019 333 citations Ying Zhu, Jing Yang et al. profile →
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives

2021 220 citations Yan Zheng, Le Zhu et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yan Zheng China	27	1.8k	1.3k	682	552	359	48	3.0k
Tongsen Zheng China	30	1.8k 1.0×	1.1k 0.8×	876 1.3×	688 1.2×	466 1.3×	63	3.2k
Dawei Rong China	23	1.8k 1.0×	1.4k 1.1×	598 0.9×	509 0.9×	546 1.5×	35	2.8k
Yu‐Shui Ma China	31	1.9k 1.0×	1.3k 1.0×	619 0.9×	332 0.6×	339 0.9×	117	3.0k
Lixia Xu China	30	1.6k 0.9×	966 0.7×	622 0.9×	286 0.5×	399 1.1×	106	2.8k
Guihua Chen China	29	1.7k 0.9×	910 0.7×	605 0.9×	824 1.5×	292 0.8×	85	3.2k
Annamaria Rapisarda United States	26	2.0k 1.1×	1.9k 1.5×	1.1k 1.6×	881 1.6×	353 1.0×	38	3.8k
Yingchao Wang China	32	2.3k 1.2×	1.4k 1.1×	588 0.9×	375 0.7×	298 0.8×	148	3.7k
Rongcheng Luo China	35	2.4k 1.3×	1.3k 1.0×	1.1k 1.6×	502 0.9×	686 1.9×	207	4.2k
Limin Xia China	39	2.8k 1.5×	1.4k 1.1×	1.0k 1.5×	594 1.1×	512 1.4×	142	4.1k

Countries citing papers authored by Yan Zheng

Since Specialization

Citations

This map shows the geographic impact of Yan Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Zheng more than expected).

Fields of papers citing papers by Yan Zheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Zheng. The network helps show where Yan Zheng may publish in the future.

Co-authorship network of co-authors of Yan Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Zheng. A scholar is included among the top collaborators of Yan Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Zheng. Yan Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiaonan, et al.. (2025). The nonlinear relationship between built environment and cycling propensity for different travel purposes − based on extreme gradient boosting decision tree. Scientific Reports. 15(1). 25901–25901.

Xu, Xiangxiang, Lu Diao, Jin Wang, et al.. (2025). Maximizing Efficacy of Cancer Nanovaccines and Immune Cells Landscape in Responders and Non‐Responders to Immunotherapy (Adv. Sci. 35/2025). Advanced Science. 12(35). 4 indexed citations

Si, Yuqi, Lizhu Chen, Yan Zheng, et al.. (2025). The effect of acupuncture on blood glucose control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology. 16. 1596062–1596062. 1 indexed citations

Wang, Junfeng, et al.. (2024). Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19. World Journal of Gastrointestinal Oncology. 16(5). 2113–2122.

Wang, Shun, Yan Zheng, Da Xu, et al.. (2024). Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma. Cell Reports Medicine. 5(2). 101415–101415. 42 indexed citations

Shen, Jie, Hui Chen, Mengjia Zhao, et al.. (2024). Oral microbiome diversity and diet quality in relation to mortality. Journal Of Clinical Periodontology. 51(11). 1478–1489. 7 indexed citations

Fu, Yan, Hao Wang, Shun Wang, et al.. (2024). Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis. Signal Transduction and Targeted Therapy. 9(1). 63–63. 21 indexed citations

Aviña‐Zubieta, J. Antonio, et al.. (2023). POS0566 SURVIVAL ON TREATMENT AFTER SWITCHING TO A BIOSIMILAR: POPULATION-BASED EVIDENCE FROM A NATURAL EXPERIMENT DUE TO A POLICY CHANGE. Annals of the Rheumatic Diseases. 82. 551–552. 1 indexed citations

Hu, Beiyuan, Tiantian Zou, Wei Qin, et al.. (2022). Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma. Cancer Research. 82(20). 3845–3857. 104 indexed citations

10.

Shao, Weiqing, Wenwei Zhu, Qin Li, et al.. (2022). Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma. Cell Reports. 39(3). 110712–110712. 23 indexed citations

11.

Yang, Xiaodong, Xiaoqin He, Shaoqing Xu, et al.. (2022). Effect of <i>Lacticaseibacillus Paracasei</i> Strain Shirota Supplementation on Clinical Responses, Gut Microbiota and Faecal Metabolites in Patients with Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial. SSRN Electronic Journal. 2 indexed citations

12.

Zhu, Le, Haoting Sun, Shun Wang, et al.. (2020). Isolation and characterization of exosomes for cancer research. Journal of Hematology & Oncology. 13(1). 152–152. 376 indexed citations breakdown →

13.

Gao, Xiaomei, Yuan‐Yuan Sheng, Jing Yang, et al.. (2018). Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 179–179. 48 indexed citations

14.

Zhang, Yu, Xiaomei Gao, Ying Zhu, et al.. (2018). The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 93–93. 33 indexed citations

15.

Luo, Qin, Chaoqun Wang, Luyu Yang, et al.. (2017). FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells. Cancer Letters. 417. 21–34. 71 indexed citations

16.

Yang, Xin, Lei Liang, Xiaofei Zhang, et al.. (2013). MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology. 58(1). 158–170. 245 indexed citations

17.

Zhou, Chuang, Haijun Zhou, Xiaofei Zhang, et al.. (2012). Postoperative Serum Osteopontin Level is a Novel Monitor for Treatment Response and Tumor Recurrence after Resection of Hepatitis B–related Hepatocellular Carcinoma. Annals of Surgical Oncology. 20(3). 929–937. 23 indexed citations

18.

Zheng, Yan. (2009). Ginseng Polysauharides Interfering Changes of Lipid Peroxidation During Hepatic Ischemia Reperfusion in Rabbits. 2 indexed citations

19.

Zhang, X.-C., Yan Zheng, Jing Ren, et al.. (2009). Aberrant Notch signaling: A potential pathomechanism of vitiligo. Medical Hypotheses. 73(1). 70–72. 11 indexed citations

20.

Swanson, Kena A., et al.. (2004). Flt3-Ligand, IL-4, GM-CSF, and Adherence-Mediated Isolation of Murine Lung Dendritic Cells: Assessment of Isolation Technique on Phenotype and Function. The Journal of Immunology. 173(8). 4875–4881. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact